← Back to headlines
Guggenheim reiterates Buy on EyePoint stock after mixed trial data By Investing.com - Investing.com India
Guggenheim reiterates Buy on EyePoint stock after mixed trial data By Investing.com Investing.com India
17 Aug, 17:50 — 17 Aug, 17:50
Sources
Showing 1 of 1 sources
Related Stories
Italy Extends Diesel Fuel Tax Cut Through Early September
18m ago
Cisco Abandons Traditional Hardware Restrictions to Pursue AI Infrastructure Boom
28m ago
Executives at Itron and Lyft Sell Significant Company Stock Holdings
30m ago
Senior Official Firmly Rejects External Political Pressure and Influence Attempts
30m ago